Verastem, Inc. (NASDAQ:VSTM) announced the pricing of its previously announced underwritten public offering of 7,250,000 shares of its common stock, offered at a price of $6.50 per share to the public. The net proceeds to Verastem from this offering are expected to be approximately $44.1 million, after deducting underwriting discounts and commissions and offering expenses. On Thursday shares of Verastem, Inc. (NASDAQ:VSTM) closed at $7.00. Company’s EPS growth for next 5 years is recorded as 1.74%.
SanDisk Corp. (NASDAQ:SNDK) announced results for the fourth quarter and fiscal year ended December 28, 2014. Fourth quarter revenue of $1.74 billion was slightly higher on a year-over-year basis and decreased 1 percent sequentially. Total revenue for fiscal 2014 was a record $6.63 billion, a 7 percent increase from $6.17 billion in fiscal 2013. SanDisk Corp. (NASDAQ:SNDK) in last trading activity moved down -1.91% to close at $78.90. Company weekly performance is -1.35% while its quarterly performance stands at -10.69%. SanDisk Corp. (NASDAQ:SNDK) is -26.99% away from its 52 week high.
International Paper Company (NYSE:IP) had its price target upped by Barclays from $62.00 to $63.00 in a research note issued to investors on Tuesday. The firm currently has an overweight rating on the stock. On last trading day International Paper Company (NYSE:IP) increased 1.08% to close at $55.18. Its volatility for the week is 1.61% while volatility for the month is 1.61%. IP’s sales growth for past 5 years was 3.20% and its EPS growth for past 5 years was 24.60%. International Paper Company (NYSE:IP) monthly performance is 2.22%.
On 20 January Enzymotec Ltd. (NASDAQ:ENZY) announced the initiation of a clinical study to evaluate the long term efficacy of Vayacog® in patients with Mild Cognitive Impairment (“MCI”). Vayacog is a proprietary prescription medical food for the dietary management of lipid imbalances associated with early memory impairment. Vayacog provides phosphatidylserine enriched with DHA, a unique lipid composition essential for the management of key biochemical modifications underlying losses in brain function. Enzymotec Ltd. (NASDAQ:ENZY) has institutional ownership stands at 62.00%. In last trading activity company’s stock closed at $7.00.
PetMed Express, Inc. (NASDAQ:PETS) reported third quarter EPS of $0.24 Tuesday morning, up from $0.23 in the previous year. Analysts expected EPS of 0.22. On last trading day PetMed Express, Inc. (NASDAQ:PETS) moved down -0.68% to close at $16.09. Its volatility for the week is 4.74% while volatility for the month is 3.04%. PETS’s sales growth for past 5 years was 1.20% and its EPS growth for past 5 years was -1.70%. PetMed Express, Inc. (NASDAQ:PETS) monthly performance is 14.93%.